H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 11.9% of adults in New York have diagnosed diabetes — about even with the U.S. 12% figure. Census population 8,336,817. New York Medicare wound biologics: National Government Services (NGS) (JK). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed New York clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a New York storefront.
Chronic Wound Treatment That Works in New York, NY for clinics & physicians. Effective chronic wound treat… Compliance support & pricing — contact Hawk Medical.
Joe Bradley will tell you the same thing he tells his own staff: epidemiology first, then MAC, then SKU. CDC PLACES (2023, crude) estimates 11.9% of adults in New York have diagnosed diabetes — about even with the U.S. 12% figure. 10.6% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. Then we pick chronic wound treatment against that mix.
National Chronic Wound Treatment That Works notes (how the product actually works)JK reviewers still want serial wound measurements and conservative-care history before CTPs, whether diabetes in New York is 11.9% or not. PLACES is planning data. The LCD is the claim.
Vendor consolidation is boring on purpose: one account, IFUs filed, JK articles mapped. 10.6% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. Pricing scripts have to match that mix. We will help write them. We will not book your patients.
CDC PLACES (2023, crude prevalence) estimates 11.9% of adults — about even with the U.S. 12% figure. Obesity is 25.1%; arthritis is 19.9%. That is place-level BRFSS modeling, not a clinic census and not a New York trial.
No. /kw pages explain distribution options. Protocol, privilege, and informed consent remain with the licensed New York clinician.
Often yes, which is the point of vendor consolidation. Keep DME delivery tickets and HCT/P lot files separate so a New York audit trail stays clean.
No. PRP (autologous) and cellular/tissue products (allograft/skin substitutes) sit on different coding and coverage paths. National Government Services (NGS) LCDs for CTPs do not automatically cover PRP injections. Build separate protocols and fee tickets.
If you operate in New York and another MAC state, say it on the first call. JK will not port 1:1. We would rather split utilization than watch a sister clinic copy New York tickets into the wrong jurisdiction.
Contact us to learn how Hawk Medical supports practices in New York, NY.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for New York is JK geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for New York — about even with the U.S. 12% figure. Planning input, not an outcomes claim.
New York Part B wound biologics follow this contractor (siblings: CT, MA, ME, NH, RI, VT). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in New York. Useful for joint-program math; still needs a diagnosis and privileging.
No New York storefront. Joe Bradley is an active practice owner. chronic wound treatment stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.